Guidelines to outcomes: clinical leadership in atrial fibrillation.
In December 2008, delegates attending a symposium in Barcelona sponsored by sanofi-aventis on atrial fibrillation debated how clinical care could be improved to meet the challenge of caring for increasing numbers of patients with atrial fibrillation and preventing its complications. This report reproduces selected excerpts from the presentations, summarizes the discussion and highlights key learning points for clinicians across the UK.
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D006333:Heart Failure / Q000150:complications; D006801:Humans; D017410:Practice Guidelines as Topic; D011787:Quality of Health Care; D016896:Treatment Outcome
D000889:Anti-Arrhythmia Agents